Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
Biden’s budget request for NCI would set back Sharpless’s goal of raising R01 paylines to 15%
NCI

Biden’s budget request for NCI would set back Sharpless’s goal of raising R01 paylines to 15%

June 18, 2021
Vol.47 No.24
By Alexandria Carolan
ARPA-H would launch 1,000 drugs, Eric Lander promises NIH advisors
News Analysis

ARPA-H would launch 1,000 drugs, Eric Lander promises NIH advisors

June 18, 2021
Vol.47 No.24
By Matthew Bin Han Ong
Senate leaders show bipartisan support for Biden’s FY22 request to increase NIH budget by $9B, including $6.5B for ARPA-H
FreeWhite House

Senate leaders show bipartisan support for Biden’s FY22 request to increase NIH budget by $9B, including $6.5B for ARPA-H

June 04, 2021
Vol.47 No.22
By Matthew Bin Han Ong
Here’s something for the Bidens and ARPA-H to do: Build a national, federated ecosystem for digital health, MITRE proposes
Conversation with The Cancer LetterReal-world Evidence

Here’s something for the Bidens and ARPA-H to do: Build a national, federated ecosystem for digital health, MITRE proposes

May 21, 2021
Vol.47 No.20
By Matthew Bin Han Ong
David Tuveson: NCI needs more funding to increase success rate of RPGs
Capitol Hill

David Tuveson: NCI needs more funding to increase success rate of RPGs

May 21, 2021
Vol.47 No.20
By Alexandria Carolan
Biden urges Congress to fund ARPA-H as OSTP nominee Eric Lander defines agency’s mission

Biden urges Congress to fund ARPA-H as OSTP nominee Eric Lander defines agency’s mission

April 30, 2021
Vol.47 No.17
By Matthew Bin Han Ong
We ask MIT’s Vander Heiden to delineate science from engineering—and NCI from ARPA-H
Conversation with The Cancer Letter

We ask MIT’s Vander Heiden to delineate science from engineering—and NCI from ARPA-H
“The lines are much more blurred in terms of what’s an engineering problem and what’s a basic science problem.”

April 23, 2021
Vol.47 No.16
By Matthew Bin Han Ong and Paul Goldberg
Chernobyl: a 35 year follow up on long-term health effects
Cancer History ProjectFreeGuest Editorial

Chernobyl: a 35 year follow up on long-term health effects

April 23, 2021
Vol.47 No.16
By Robert Peter Gale
Sharpless: ARPA-H and NCI should help each other to “end cancer as we know it”
NCI

Sharpless: ARPA-H and NCI should help each other to “end cancer as we know it”

April 16, 2021
Vol.47 No.15
By Matthew Bin Han Ong
The Moonshot’s Metric for Success: Avoiding a Single, Tangible Endpoint
Free

The Moonshot’s Metric for Success: Avoiding a Single, Tangible Endpoint

June 24, 2016
Vol.42 No.25

Posts navigation

Previous1…3637

Trending Stories

  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
  • Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
  • One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
  • As more people are surviving cancer, we must continue funding bold science
  • GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
    Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account